Nanome
Private Company
Total funding raised: $18M
Overview
Nanome is a private, San Diego-based company founded in 2015 that provides a spatial computing and AI software platform for scientific research and drug discovery. Its technology combines immersive virtual reality (Nanome XR) for 3D molecular visualization and collaboration with an AI-powered conversational interface (MARA) for managing chemical data and computational workflows. The company targets enterprise customers in the pharmaceutical and biotechnology sectors, as well as academic institutions, with a platform-as-a-service business model, positioning itself as a productivity-enhancing tool rather than a drug developer. Nanome has demonstrated validation through published studies and testimonials from top-tier pharmaceutical companies.
Technology Platform
Combined virtual reality (XR) spatial computing platform (Nanome XR) and an AI-powered conversational data interface (MARA) for molecular visualization, collaborative drug design, and scientific data management.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Nanome competes with traditional 2D molecular visualization and modeling software suites (e.g., from Schrödinger, Dassault Systèmes BIOVIA, OpenEye). It also faces emerging competition from other VR/AR science startups and potential disruption from large tech companies (e.g., NVIDIA) developing platforms for scientific simulation and collaboration. Its differentiator is the deep integration of immersive collaboration with an AI data copilot.